MediGene (MDG1) Given a €22.00 Price Target by Baader Bank Analysts

Baader Bank set a €22.00 ($27.16) target price on MediGene (ETR:MDG1) in a report published on Wednesday. The firm currently has a buy rating on the stock.

A number of other equities analysts have also weighed in on MDG1. Oddo Bhf set a €13.00 ($16.05) price target on shares of MediGene and gave the stock a neutral rating in a research report on Friday, March 23rd. Independent Research set a €16.50 ($20.37) target price on shares of MediGene and gave the company a neutral rating in a report on Thursday, March 22nd.

How to Become a New Pot Stock Millionaire

MDG1 opened at €13.70 ($16.91) on Wednesday. MediGene has a twelve month low of €8.53 ($10.53) and a twelve month high of €19.27 ($23.79).

ILLEGAL ACTIVITY WARNING: “MediGene (MDG1) Given a €22.00 Price Target by Baader Bank Analysts” was posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this report on another website, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this report can be accessed at https://www.tickerreport.com/banking-finance/3336968/medigene-mdg1-given-a-22-00-price-target-by-baader-bank-analysts.html.

MediGene Company Profile

Medigene AG, a biotechnology company, develops immunotherapy platforms to treat a range of cancers in various stages. It operates through two segments, Immunotherapies and Other Products. The company develops Dendritic cell vaccines in phase I/II clinical trials; and T-cell receptor-modified T cells and T-cell-specific monoclonal antibodies in preclinical development phase.

Receive News & Ratings for MediGene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediGene and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

WNS Global Services  Expected to Post Earnings of $0.57 Per Share
WNS Global Services Expected to Post Earnings of $0.57 Per Share
-$0.04 EPS Expected for Coeur Mining  This Quarter
-$0.04 EPS Expected for Coeur Mining This Quarter
Head-To-Head Analysis: Omni Lite Industries Canada  vs. Park-Ohio
Head-To-Head Analysis: Omni Lite Industries Canada vs. Park-Ohio
Reviewing Caladrius Biosciences  & Tivity Health
Reviewing Caladrius Biosciences & Tivity Health
Comparing Pacific Ethanol  and Its Peers
Comparing Pacific Ethanol and Its Peers
Somewhat Positive Media Coverage Somewhat Unlikely to Affect Capital Product Partners  Share Price
Somewhat Positive Media Coverage Somewhat Unlikely to Affect Capital Product Partners Share Price


© 2006-2018 Ticker Report. Google+.